Browse Drug Recalls
2,151 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 2,151 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 2,151 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Jun 24, 2019 | Acetaminophen Children's Liquid, 160 mg/5 mL, 4 oz bottle, Manufactured by To... | Microbial Contamination of Non-sterile Products: Potential product contamination with Burkholderi... | Class II | H J Harkins Company Inc dba Pharma Pac |
| Jun 18, 2019 | Naloxone HCL Preserved INJ, 500mg/50mL (10mg/mL), 50mL Sterile MDV, Rx only, ... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 18, 2019 | Phenylephrine HCL PF INJ in 0.9% Sodium Chloride, 1000mcg/10mL (100mgc/mL), *... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 18, 2019 | Orphenadrine Citrate Sterile Injectable Solution *Contains Sulfites*, 30mg/mL... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 18, 2019 | Mitomycin Preservative Free Irrigation, 40mg/10mL (4mg/mL), 10mL SDV, Rx only... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 18, 2019 | Riboflavin 5-Phosphate Sodium Ophthalmic Solution, 19.05mg/3mL (6.35 mg/mL), ... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 18, 2019 | Isoproterenol HCL in D5W (Sterile to Sterile), 200mcg/50mL (4mcg/mL), 50mL St... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 18, 2019 | Dexamethasone Sodium Phosphate Preservative Free Sterile Solution for INJ, 24... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 18, 2019 | Lidocaine 0.5%/Phenylephrine 0.75% P.F. INJ, 1mL Sterile SDV, Rx only, Premie... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 18, 2019 | ChlorproMAZINE HCL INJ, 25mg/mL, *Contains Sulfites*, 1mL in a 5mL Sterile SD... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 18, 2019 | Atropine Sulfate PF INJ, 0.8 mg/2 mL (0.4 mg/mL), 2mL Single Dose Syringe, Rx... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 18, 2019 | Isoproterenol HCL in D5W, 500mcg/50mL (10mcg/mL), 50mL Sterile Single-Dose Ba... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 18, 2019 | Sodium Bicarbonate INJ 8.4%, 50 mEq/50mL (84mg/mL) (1mEq/mL), 50mL Sterile SD... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 18, 2019 | Isoproterenol HCL in D5W (Non Sterile to Sterile), 200mcg/50mL (4mcg/mL), 50m... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 18, 2019 | SUCCINYLcholine Chloride, 200mg/10mL (20mg/mL), 10mL Sterile Single Dose Syri... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 18, 2019 | SUCCINYLcholine Chloride, 100mg/5mL (20mg/mL), 5mL Sterile Single-Use Syringe... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 18, 2019 | Neostigmine Methylsulfate, 5mg/5mL (1mg/mL), 5mL Single Dose Syringe, Rx only... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 18, 2019 | Brilliant Blue Ophthalmic PF INJ, 0.5mg/mL (0.05%), 1 mL SDV, Rx only, Premie... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 18, 2019 | Droperidol Injectable Sterile Solution, 0.625mg/mL, 1mL in a 3mL Sterile Sing... | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potenti... | Class II | Premier Pharmacy Labs Inc |
| Jun 10, 2019 | Robafen DM, Generic for Robitussin DM, In each teaspoonful (5mL): Dextrometho... | CGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Preferred Pharmaceuticals, Inc |
| Jun 5, 2019 | Cetirizine Oral Solution 1 mg/mL, Children's Allergy, Antihistamine, Dye Free... | cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL... | Class II | P & L Developments, LLC |
| Jun 5, 2019 | Cetirizine HCL Oral Solution 1 mg/mL, Children's Allergy, Antihistamine, Dye ... | cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL... | Class II | P & L Developments, LLC |
| Jun 5, 2019 | Cetirizine Oral Solution 1 mg/mL, Up & Up, Children's allergy relief, Antihis... | cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL... | Class II | P & L Developments, LLC |
| May 31, 2019 | Preferred Plus Pharmacy Iron Elixir Ferrous Sulfate, 220 mg, 16 fl oz. (473 m... | cGMP Deviations: Products may have microbial contamination. | Class II | Geritrex, LLC |
| May 31, 2019 | Ritussin DM Children & Adults, 4 Fl. Oz. (118 mL), RIJ Pharmaceutical Corpora... | cGMP Deviations: Products may have microbial contamination. | Class II | Geritrex, LLC |
| May 31, 2019 | Ritussin DM Double Strength, 4 FL. OZ. (118 mL), RIJ Pharmaceutical Corporati... | cGMP Deviations: Products may have microbial contamination. | Class II | Geritrex, LLC |
| May 31, 2019 | Gericare Iron Supplement Elixir Ferrous Sulfate, 220 mg, 16 fl oz. (473 mL), ... | cGMP Deviations: Products may have microbial contamination. | Class II | Geritrex, LLC |
| May 31, 2019 | Diphenhydramine Oral Liquid Alcohol Free, 12.5 mg/5 mL, 4 fl oz (118 mL), RIJ... | cGMP Deviations: Products may have microbial contamination. | Class II | Geritrex, LLC |
| May 31, 2019 | Gericare Diocto Liquid Docusate Sodium Stool Softener, 50 mg/5mL, 16 FL OZ (4... | cGMP Deviations: Products may have microbial contamination. | Class II | Geritrex, LLC |
| May 31, 2019 | Gericare Geri-Tussin DM, 16 FL OZ (473 mL), Geri-care Phamaceuticals Corp. 16... | cGMP Deviations: Products may have microbial contamination. | Class II | Geritrex, LLC |
| May 31, 2019 | Preferred Plus Dioctyl Liquid Stool Softener (Docusate Sodium), 50mg/5mL, 16 ... | cGMP Deviations: Products may have microbial contamination. | Class II | Geritrex, LLC |
| May 21, 2019 | Biscolax Laxative (Bisacodyl, USP 10 mg), a) 12 suppositories per carton, NDC... | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | Pedia Relief Cough-Cold Oral Solution, Alcohol free, antihistamine, cough sup... | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | Nasal Decongestant Spray Regular, Oxymetazoline HCl 0.05%, a) 0.5 FL. oz. (15... | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | Allergy Liquid Antihistamine, Diphenhydramine HCl USP 12.5 mg/5 mL), Alcohol ... | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | Hyoscyamine Sulfate Elixir 0.125 mg per 5 mL, Rx Only, 473 mL (16 oz.) bottle... | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | Phenobarbital Oral Solution, USP, 20 mg per 5 mL, Rx Only, One Pint (473 mL) ... | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | Robafen DM Syrup (Dextromethorphan HBr, USP 20 mg/10 mL and Guaifenesin, USP ... | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | Diphenhist Oral Solution (Diphenhydramine HCl, USP), 12.5 mg/5 mL, a) 4 FL. o... | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | Cetirizine HCL Oral Solution, USP 1mg/mL, 4 oz - BULK, PLD | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | Robafen DM Cough Sugar-Free Clear Cough Expectorant (Dextromethorphan HBr, US... | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | Bisacodyl Suppositories, Brite Stock, Reese. | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | Cetirizine Hydrochloride Oral Solution, USP 1mg/mL, Fr Oral Use Only, Rx only... | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | Lactulose Solution, USP 10 g/15 mL, For Oral Administration, Rx Only, a) 16 F... | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | Guaifenesin AC Cough Syrup (Guaifenesin and Codeine Phosphate Oral Solution, ... | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | Cyproheptadine Hydrochloride Syrup Oral Solution, USP, 2mg/5mL, 473 mL (16 FL... | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | Pain & Fever Oral Solution (Acetaminophen 160 mg/5 mL), Sugar free, Aspirin &... | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | Robafen AC Oral Solution (Guaifenesin and Codeine Phosphate Oral Solution, US... | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | RisperiDONE Oral Solution, USP, 1 mg/mL, Rx Only, 30 mL bottle, NDC 13668-589... | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
| May 21, 2019 | Laxative Suppositories (Bisacodyl USP, 10 mg), a) 12 Suppositories per carton... | cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... | Class II | Torrent Pharma Inc |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.